Transcatheter heart valves technologies
Transcatheter heart valves technologies
Lipoprotein(a) and High‐Sensitivity C‐Reactive Protein Compound the Risk of Hypoattenuating Leaflet Thickening After Transcatheter Aortic Valve Replacement
Abstract Background The mechanism for hypoattenuating leaflet thickening (HALT) after transcatheter aortic valve replacement is still not well elucidated, and
Transcatheter heart valves technologies
Impact of prior hospitalization for heart failure on clinical outcomes of patients after transcatheter aortic valve implantation with new‐generation devices: Insights from the LAPLACE‐TAVI registry
Abstract Background A history of hospitalization for heart failure (HHF) before transcatheter aortic valve implantation (TAVI) or surgical aortic valve
Transcatheter heart valves technologies
Successful management of acute left main coronary occlusion following transcatheter aortic valve implantation: a case report
Abstract Background Transcatheter aortic valve implantation is an established, highly effective procedure in selected patients with severe degenerative aortic valve
Transcatheter heart valves technologies
Elevated myocardial extracellular volume fraction as a new predictor of conduction defects after transcatheter aortic valve replacement
Abstract Key points Transcatheter aortic valve replacement (TAVR) is now the standard of care for patients with severe symptomatic aortic
